PT Anugrah Argon Medica (AAM) awarded as one of the Best FOI (Inhealth Drug Formulary) Drug Distributors in 2022 by PT Asuransi Jiwa Inhealth Indonesia (Mandiri Inhealth). Mr. Budi Tampubolon, President Director of Mandiri Inhealth, presented this award to Mrs. Juliwaty, President Director of AAM, on Tuesday, October 25, 2022, in Jakarta.
The highest appreciation from Mandiri Inhealth is given to AAM because it delivers the best performance in ensuring the availability of FOI drugs is maintained and is able to enhance drug services for all Mandiri Inhealth participants.
"AAM will always ensure that FOI medications are available and that Inhealth service quality are provided at the highest level. Thank you to the AAM team at the head office and branch locations for always delivering Inhealth the excellence service level," said Mrs. Juliwaty.
Mandiri Inhealth held this award ceremony at the gathering with 22 drug distributors and 76 other pharmaceutical companies.
“Congratulations to AAM! This is the commitment and the strategic role of Argon Group in supporting the improvement of public health resilience by always providing significant added value for customers and business partners," said Argon Group’s President Director, Krestijanto Pandji.